Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis

OBJECTIVE: Aripiprazole and risperidone are 2 of the most used second-generation antipsychotics (SGAs) worldwide. Previous evidence shows a similar effect of these SGAs on weight and metabolic changes in the short term. However, a longer period is necessary for a better assessment of the SGA´s metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Vázquez-Bourgon, Javier, Ortiz-García de la Foz, Víctor, Gómez-Revuelta, Marcos, Mayoral-van Son, Jacqueline, Juncal-Ruiz, María, Garrido-Torres, Nathalia, Crespo-Facorro, Benedicto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593219/
https://www.ncbi.nlm.nih.gov/pubmed/35641112
http://dx.doi.org/10.1093/ijnp/pyac033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593219/
https://www.ncbi.nlm.nih.gov/pubmed/35641112
http://dx.doi.org/10.1093/ijnp/pyac033

Ejemplares similares